Behind the Success of cyclodextrin excipient Development
We make cyclodextrin excipient development easy based on our strong R&D strength.
R&D Team with 10+ Years of Average Experience
ZHIYUAN’s versatile R&D team are competent for helping develop marketable cyclodextrin. Our R&D’s mission is explore cyclodextrin infinite applications, to provide life health and skincare solutions that arrive at your expectations. As such, we constantly update cyclodextrin developments to reach the standards of your end users.
State-of-the-Art Lab
Since ZHIYUAN is an innovative and technique-driven cosmetic manufacturer, we have established a professional cosmetics laboratory to meet the development and testing of all formulations. Following the GMP standards for R&D and validation processes, our well-organized lab ensures that you can get an accurate and tested formulation in a short lead time.
Stay in Sync with the Market
Our team of researchers formulate careful market analysis to assist in product development. We study the trends and regulations of the international raw material market to determine our formulation development. Rely on our quality studies to increase vitality of your brand and target more end users.
Take a Tour on Our Lab
Guaranteed quality and safe use are the first priorities of our laboratory.
R&D Achievements
Hydroxypropyl beta cyclodextrin and sulfobutyl beta cyclodextrin sodium have been registered with the FDA and successfully registered with the CDE. Hydroxypropyl beta cyclodextrin oral registration number F20209990366 (status “A”), injection registration number F20180001469, sulfobutyl beta cyclodextrin sodium CDE registration number F20190000285 (status “A”), methyl beta cyclodextrin CDE registration number F20210000272, and hydroxypropyl gamma cyclodextrin CDE registration number F20220000042.
